Par Health Issues Voluntary Nationwide Recall of Two Lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) Due to the Presence of Particulate Matter
ROCHESTER, Mich., Oct. 8, 2026 /PRNewswire/ -- Par Health is voluntarily recalling two lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) to the hospital level. The product is being recalled due to the presence of particulate matter identified as cellulose....
Covered in this story
Call it yourself
No calls on $PAR yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Par Technology Corp →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.